As you know, we have been part of the distribution of Albendazole for the past five years. This is a medication we administer every six months for those infected with intestinal parasites.Recently, CALI held a meeting
with the networking organizations of Albndazole such as Food For the Hungry and Yuacana Huasy who promote and distribute the pills along side CALI. Andy Koval from Alexandria, VA , co-founder of MedPharm, presented at this meeting. He gave information about MedPharm, a pharmacutical company who has been involved in the research and production of anti-parasitic medications for over twenty years.
with the networking organizations of Albndazole such as Food For the Hungry and Yuacana Huasy who promote and distribute the pills along side CALI. Andy Koval from Alexandria, VA , co-founder of MedPharm, presented at this meeting. He gave information about MedPharm, a pharmacutical company who has been involved in the research and production of anti-parasitic medications for over twenty years. After Mr. Koval gave an introduction on the Albendazole network of MedPharm, we then conducted a video conference with Andy´s medical doctor, Jose Mosquera. Dr. Mosquera reassured us that the purpose of this medication is to help reduce the overall population of intestinal parasites in a person thereby reducing the total egg count. Our objective at this moment is not total intestinal parasite elimination for a concentrated few, but instead to reach as many people as possible.
Dr. Mosquera then enlightened us about a new medication called Nitezole. Nitezole is a combination of 200 mg of Mebendazole and 200 mg of Tinidazole. Together, they work to treat soil helminth parasites, ameobas, and girardia. Also, MedPharm informed us that they are willing to donate Nitezole to CALI for mass distribution through our network. After verifying the effectiveness of Nitezole, we will consider it for distribution starting here in Peru. Thanks to an offer made by the U.S./Peruvian Naval Medical Research on Topical Diseases(NAMRED) located here in Lima, research on the effectiveness of Nitezole will be a joint effort between MedPharm, NAMRED, and CALI. When NAMRED´s results are in, we hope to expand the distribution of this new medication in many new areas of Peru.
CALI is very thankful to have so many partners willing to help in the distribution of this pill. If all goes well with the research f
indings of Nitezole, we will be receiving at least one million pills to administer all across Peru. We cannot wait to see a more worm free (oops), parasite- free Peru!
indings of Nitezole, we will be receiving at least one million pills to administer all across Peru. We cannot wait to see a more worm free (oops), parasite- free Peru! 